ISSN: 1948-5964
+44 1300 500008
Gary Kobinger
Head, Vector Design and Immunotherapy, Special Pathogens Program, National Microbiology Labororatory, Public Health Agency of Canada
Dr. Gary Kobinger is the lab's chief of special pathogens, heading a team that works on some of the world's worst disease threats. Gary Kobinger international experience includes various programs, contributions and participation in different countries for diverse fields of study. Gary Kobinger research interests reflect in wide range of publications in various national and international journals. Dr. Kobinger’s main interest is the development and testing of novel vaccine platforms for different applications including the protection against emerging pathogens.
Vaccines, Vaccination, Drug development, Drug Discovery